Contact information

  1. Nf-κB and MCL-1 are important determinants for the effectiveness of bortezomib in AML CD34+ cells

    Bosman, M., Schuringa, J., Quax, W. & Vellenga, E., 1-Aug-2012, In : Experimental Hematology. 40, 8, p. 141-142 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (1) »

View graph of relations

ID: 37233